Regulated Industry Infrastructure

Regulated Industry
Workflows

Aregis helps startups, growing businesses, and mid-market teams manage regulated products and operations without losing control of quality, obligations, suppliers, or important decisions.

Start here

AI and Digital Readiness for Sponsors

Most sponsors start here, in three steps: an AI opportunity analysis shows where AI would help and where it should stay out, AI policy and procedure writes the rules into the QMS, and workforce training prepares staff to use approved tools under those rules. All three are available now.

Strategic and Tactical Experts for Regulated Work

Regulated work becomes difficult when responsibilities are unclear, specialists work in separate systems, or proof is gathered too late. Aregis brings experts who can set the strategy and do the work, and keeps progress and supporting records visible from the start.

Know What Done Means

We agree on the deliverables, deadlines, responsibilities, and success criteria before work begins.

Keep Priorities Clear

Teams can see what needs attention now, what is waiting on something else, and who owns the next step.

Build the Record as You Work

Reviews, decisions, and supporting evidence are captured along the way instead of reconstructed before an audit or deadline.

Use the Expertise You Need

Aregis can coordinate internal teams, consultants, and service providers without requiring a growing company to build every capability in-house.

Who We Help

Our initial focus is startups, small and midsize businesses, and mid-market teams that need experienced help without adding a large permanent department.

REGULATED PRODUCTS

Pharma, Biotech and Medical Device Teams

Teams preparing a product, quality system, submission, manufacturing process, audit, inspection, or remediation program.

REGULATED OPERATIONS

Manufacturing and Growing Operations

Organizations that need clearer quality controls, supplier oversight, validation, documentation, or coordination as operations grow.

CONTROLLED WORKFLOWS

AI, Digital, Contract and Supplier Teams

Teams introducing AI or digital tools, managing important contracts, or strengthening supplier processes where decisions and obligations must be traceable.

How GAME Plan Helps

Growing teams often know the goal but struggle to keep priorities, ownership, dependencies, and proof of completion in one place. GAME Plan, Aregis's planning and delivery system, is available now and keeps that shared view current for the engagement.

Generate — Define the Work

Break the goal into clear work with an owner, expected result, deadline, and definition of done.

Attribute — Show Who Contributed

Record who owns the work and who contributed, including internal staff, consultants, and service providers.

Measure — Keep Progress Visible

See what is ready to move, what is blocked, what has changed, and where a decision is needed.

Evidence — Prove Completion

Attach the review, decision, document, or other proof that shows the work met its agreed requirement.

Ways We Can Help

AI and digital readiness comes first for most sponsors, in three steps: an AI opportunity analysis shows where AI would help the work they already do and where it should stay out, AI policy and procedure writes the rules into the QMS, and workforce training on AI use prepares people to follow them. Other services can stand alone or follow from them. Each engagement is sized around the problem, the team already in place, and the result the organization needs.

01 · AI Opportunity Step 1

AI Opportunity Analysis for Sponsors

Why it matters Sponsors need a clear view of where AI can help regulated work before they write policy, train people, or put a tool into a process.

A current consulting engagement. Aregis reviews the sponsor's quality, regulatory, and program work, identifies where AI could help and where it should not, and turns that review into a prioritized opportunity matrix. Qualified people at the sponsor decide what to pursue. The analysis can lead into AI policy and procedure, workforce training on AI use, or a bounded workflow.

  • Review of sponsor processes where AI could change the work
  • Constraints for data, human review, and existing SOPs
  • Prioritized opportunity matrix with an owner for each item
  • Recommended next step: policy, training, or a bounded workflow
See the use case →
02 · AI + QMS Step 2

AI Policy / Procedure + HITL in the QMS

Why it matters Teams want AI leverage in quality workflows with controlled GxP risk and clear human accountability.

A current consulting service for organizations adopting AI in quality work. Aregis helps define approved uses, required human review, escalation, training, change control, and records so teams can use authorized tools without treating AI output as an unreviewed decision.

  • AI policy and procedure frameworks for QMS use
  • Human-in-the-loop roles, controls, and escalation paths
  • Change-control and training linkage for AI-enabled SOPs
  • Governance language suitable for audit scrutiny
See the use case →
03 · AI Workforce Step 3

Workforce Training on AI Use

Why it matters People are already using AI at work. Sponsors need them to know which tools are approved, what data may go in, how to check the output, and when a qualified person has to decide.

A current consulting engagement. Aregis trains the sponsor's staff to use approved AI tools under the sponsor's AI policy and SOPs. Training is set by role: what each person may use AI for, what data stays out, how to review and record the output, and when to escalate. Completion and understanding are recorded so the training can stand up to an audit. Where the policy does not exist yet, it is written first.

  • Role-based training on approved AI uses and limits
  • Data handling: what may and may not enter an AI tool
  • Reviewing, recording, and escalating AI-assisted work
  • Training records and checks that the training took hold
See the use case →
04 · CMC / RA

CMC & Regulatory Affairs

Why it matters IND / Module 3 / submission workstreams need coherent strategy, content, and stage-appropriate CMC across CRO, CMO, and internal authors.

Scoped CMC and regulatory workstreams with milestone-verified deliverables: submission strategy and content coherence (including Module 3), health-authority meeting preparation and response planning, IND / BLA / NDA / PMA / 510(k) support as applicable, and CDMO / CRO oversight so development, analytics, and quality stay stage-appropriate and inspection-aware.

  • Regulatory strategy and submission workstream leadership
  • Module 3 / CMC content coherence across partners
  • Health-authority meeting prep and response planning
  • CDMO / CRO oversight for stage-appropriate development
05 · Quality

Quality Systems — Design & Remediation

Why it matters Sponsors need a single, audit-ready evidence trail for QMS design, change control, and remediation — especially across sites or post-acquisition alignment.

Quality-system design, integration, and remediation aligned with FDA, EU MDR / IVDR, ISO 13485, 21 CFR Part 820 / QMSR, and related GxP expectations. Typical scopes include CAPA, document control, change control, supplier quality, risk management, and multi-site or post-acquisition QMS alignment — with audit-ready traceability built into the milestone map.

  • QMS design, integration, and remediation roadmaps
  • CAPA, document control, change control, supplier quality
  • Risk management and governance procedure work
  • Multi-site / post-acquisition quality alignment
06 · Audit Ready

Inspection & Audit Readiness

Why it matters ISO 13485, IVDR, or notified-body (e.g. BSI) timelines require QMS and technical-file evidence that is inspection-ready on schedule.

Inspection and notified-body readiness packages tied to real QMS and technical-file gaps — including ISO 13485, IVDR, and BSI-style audit preparation. Gap analyses, CAPA planning, mock readiness reviews, and inspection-response strategy so sponsors close findings with documented evidence and audit-ready packages.

  • Gap analysis against ISO 13485 / IVDR / applicable regs
  • Notified-body / BSI-style audit preparation
  • CAPA planning linked to readiness findings
  • Mock readiness reviews and response strategy
Related use case: procedure-to-standard gap matrix →
07 · Gap Matrix

Procedure-to-Standard Gap Matrix

Why it matters A team can have SOPs for a process and still not know which requirements they cover, which they miss, and what to change first.

Aregis maps the SOPs and practice for a process to the standard it has to meet, then turns the differences into a gap matrix with an owner and an improvement for each gap. The matrix becomes the plan for process compliance improvement, and qualified people remain responsible for the compliance conclusions.

  • Requirement-by-requirement map to current SOPs
  • Gap matrix with owner and improvement for each gap
  • Prioritized process compliance improvement plan
  • Closure evidence kept with each gap
See the use case →
08 · Complaints

Complaint Investigation Writing

Why it matters Complaint investigations have to be written from the source records, follow the complaint SOP, and show whether the event is part of a trend.

Aregis helps write complaint investigations from sanitized sources, with a reference for each material statement, a trend check against related complaints, and the human review the complaint SOP requires. Client-approved AI tools may help draft, and a qualified complaint owner remains responsible for the conclusion.

  • Source sanitization with a controlled link to the original
  • A source reference for each material statement
  • Complaint trending by product, lot, and failure mode
  • SOP-compliant human review and acceptance
See the use case →
09 · CAPA

AI-Assisted CAPA Project Management & Investigations

Why it matters Sponsors need CAPA portfolios that close with strong root cause, clear ownership, and verified effectiveness evidence.

Help teams organize CAPA backlogs, investigations, root-cause work, actions, and effectiveness checks. Client-approved AI tools may support analysis, but qualified people remain responsible for decisions, approval, and closure.

  • CAPA portfolio / program management under GAME
  • AI-assisted investigation support with human ownership
  • Root-cause and effectiveness evidence expectations
  • Backlog triage, prioritization, and closure tracking
Related use case: CAPA investigation writing →
10 · Coordination

Cross-Firm / Program Coordination

Why it matters Multi-vendor programs need one prioritized execution picture — what is unblocked, waiting, and evidenced.

When an engagement needs more than one firm — CMC, clinical operations, regulatory strategy, quality — Aregis structures cross-party milestones so sponsors keep one prioritized delivery picture. Shared baselines, transparent milestone tracking, and structured dispute paths as scope evolves, with every participant aligned to the same evidence trail.

  • Combined milestone map across specialized firms
  • Shared baselines and dependency alignment
  • Single sponsor-facing delivery picture
  • Structured dispute / scope-change paths
11 · GAME

GAME as Engagement Operating System

Why it matters Programs need clear priorities, visible dependencies, and milestones that close with proof of outcomes.

Aregis runs the engagement on GAME Plan: prioritization, dependency alignment, and verified proof of outcomes on every milestone. Program managers see what is unblocked, what is waiting, and what has evidence — from study design or remediation kickoff through regulatory submission or audit close.

  • Prioritized work graph with dependency visibility
  • Unblocked next-step clarity for sponsors and teams
  • Milestone close with verified evidence
  • Attribution against proven, evidence-backed delivery

Current engagements are human-led and may use client-approved AI tools where appropriate. Qualified people remain responsible for decisions and approvals.

See all use cases →

Important Workflows Beyond Product Compliance

The same clear ownership, controls, and evidence are useful in business workflows that carry regulatory, contractual, financial, or operational risk.

AI & Digital Workflow Governance

Help a growing team decide where AI or automation is appropriate, who reviews the output, what data may be used, how changes are approved, and what record must be kept.

Contract & Supplier Management

Connect contract terms and supplier commitments to owners, deadlines, deliverables, changes, approvals, performance records, and escalation when something goes off track.

Program & CMC Leadership

Cross-functional program leadership for Phase 1–3 and pre-IND development: stage-gates, CMC / nonclinical sub-teams, executive reporting, and milestone governance across Clinical, CMC, DMPK, Toxicology, and related functions.

PAI & Pre-Approval Readiness

Pre-approval inspection readiness for biologics and drug manufacturing — gap analysis, CAPA plans, and cross-functional remediation so quality and manufacturing systems are inspection-ready ahead of FDA review.

Sterile & Biologics CMC

Drug substance and drug product development oversight for sterile and long-acting injectable programs, including process / analytical characterization, tech transfer, and CDMO stage-appropriate readiness.

Combination Products & Design QA

Combination-product quality and design-QA support: design controls, risk-based design verification, supplier qualification, and QMS interfaces across drug / device boundaries — including inhalation and other device-platform programs.

eQMS & Compliance Systems

Training, document control, and compliance-system design or remediation — including LMS process alignment and procedure rollout — so eQMS and related systems support audit-ready operations.

Related use case: AI-assisted training system deployment

Clinical Quality Interfaces

Interfaces between clinical development and quality / regulatory delivery: clinical trial supply quality procedures, outsourced R&D / Quality / Regulatory vendor oversight, and program coordination from study design through submission readiness.

MedTech Regulatory & Design Controls

Medical device quality and regulatory oversight: design controls, ISO 14971 risk management, and 510(k) / PMA / MDR submission support with audit-ready traceability from design inputs through post-market surveillance interfaces.

Data Integrity & Audit Trail Remediation

Gap analysis and redesign of audit-trail review procedures; operational resolution of audit-trail backlog for process and analytical equipment supporting cGMP manufacturing — with documented controls and closure evidence.

Industry Expertise

Pharmaceuticals & Biotechnology

CMC and regulatory strategy, quality systems, auditing, CAPA, inspection readiness, regulated manufacturing, supplier oversight, and program leadership.

Medical Devices & Diagnostics

Design controls, risk management, quality systems, auditing, regulatory submissions, supplier controls, and manufacturing readiness.

Other Regulated Manufacturing

Quality systems, controlled processes, validation, supplier governance, audit readiness, remediation, and portfolio-level program management.

What an Engagement Looks Like

We start with the problem and the result you need. Then we define the work, confirm who is responsible, identify dependencies and risks, and agree on the records that will show completion. GAME Plan keeps that shared picture current throughout the engagement.

See how an engagement works →
Tell us what is changing, what is at risk, or where the work has become difficult to manage. Discuss the work